Mitsubishi Tanabe Pharma Corp operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Mitsubishi Tanabe Pharma Corp with three other
companies in this sector in Japan:
Taisho Pharmaceutical Holdings Co Ltd
sales of 279.77 billion Japanese Yen [US$2.50 billion]
of which 64%
Shionogi & Co Ltd
(338.89 billion Japanese Yen [US$3.03 billion]
of which 100%
was Pharmaceuticals), and
Eisai Company Limited
(539.10 billion Japanese Yen [US$4.82 billion]
of which 54%
was Pharmaceutical Business -Japan).
During the year ended March of 2017, sales at
Mitsubishi Tanabe Pharma Corp were ¥423.98 billion (US$3.79 billion).
decrease of 1.8%
versus 2016, when the company's sales were ¥431.70 billion.
The sales level in 2017 was fairly close to the level five years ago: in 2012, Mitsubishi Tanabe Pharma Corp had sales
of ¥407.16 billion.